ArticleThe American journal of case reports2025
Distinguishing Wernicke Encephalopathy from Artery of Percheron Infarction in a 43-Year-Old Man: A Case Report.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Wernicke's encephalopathy (WE) and Artery of Percheron (AOP) infarction share overlapping presentations, including mental status changes, ocular-motor signs, and similar thalamic MRI findings; but require distinct time-sensitive treatment, making prompt differentiation critical. WE results from thiamine deficiency, often due to alcohol use, causing oxidative damage in highly metabolically active brain regions. In contrast, an AOP infarction results from thrombotic occlusion of a rare perforating artery. The aim of this case report is to delineate the similarities and differences between WE and AOP infarction and to underscore the importance of early empiric thiamine replacement. CASE REPORT A 43-year-old man presented with altered mental status, fever, and generalized weakness. Non-contrast head computed tomography (CT) showed cerebellar hypoattenuation, prompting activation of a code stroke. The lesion was later deemed artifactual, and he was admitted for further evaluation. The following morning, the patient's condition acutely changed, with new oculomotor abnormalities and worsening right lower extremity weakness. An urgent brain MRI demonstrated symmetric hyperintensities in the medial thalami. Uncertain whether the lesions represented an AOP infarction or WE, the team ordered a serum thiamine analysis, which returned low. Intravenous thiamine was initiated, resulting in rapid clinical improvement, and confirming WE as the final diagnosis. CONCLUSIONS WE can closely mimic AOP infarction both on clinical presentation and on radiologic appearance. High-dose thiamine is a low-risk, potentially lifesaving intervention, particularly when initial CT imaging is nondiagnostic and further imaging is pending. Empiric thiamine administration is especially warranted if MRI shows bilateral thalamic lesions of uncertain etiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.